drugset / Trial / NCT02052362
Bioavailability of ABT-450 and ABT-267 With Ritonavir
Non-randomizedParallel-groupOpen-label
Summary
A study to investigate the fraction of ABT-267 and ABT-450 absorbed by the body when given in combination with each other and Ritonavir(r).
Timeline
- Start
- 2014-01
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ombitasvir | Small molecule | — | — |
| Subject | paritaprevir | Small molecule | — | — |
| Background | Ritonavir | Other / unclassified | — | — |
Indications
No indication recorded.